2\) Patients whose asthma is not controlled with more than three months of using high dose inhaled steroids and long acting β2-agonists
3\) Patients with pre-bronchodilator FEV1 is between sixty and eighty-five%
4\) Patients who do not improve through continuous drug uses.
You may not be if
1\) Presence of a pacemaker, internal defibrillator, or other implantable electronic devices,
2\) Known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines.
3\) Patients previously treated with the Alair System should not be retreated in the same area(s). No clinical data are available studying the safety and/or effectiveness of repeat treatments.
4)Active respiratory infection
5\) Asthma exacerbation or changing dose of systemic corticosteroids for asthma (up or down) in the past 14 days.
6\) Known coagulopathy.
7\) As with other bronchoscopic procedures, patients should stop taking anticoagulants, antiplatelet agents, aspirin and NSAIDS before the procedure with physician guidance.
